Twist Bioscience Corporation (TWST)
Market Cap | 2.76B |
Revenue (ttm) | 277.49M |
Net Income (ttm) | -192.14M |
Shares Out | 58.23M |
EPS (ttm) | -3.36 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 899,026 |
Open | 48.82 |
Previous Close | 48.93 |
Day's Range | 46.04 - 48.84 |
52-Week Range | 14.42 - 55.26 |
Beta | 1.78 |
Analysts | Strong Buy |
Price Target | 46.63 (-1.46%) |
Earnings Date | Aug 2, 2024 |
About TWST
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other ap... [Read more]
Financial Performance
In 2023, TWST's revenue was $245.11 million, an increase of 20.41% compared to the previous year's $203.57 million. Losses were -$204.62 million, -6.08% less than in 2022.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for TWST stock is "Strong Buy." The 12-month stock price forecast is $46.63, which is a decrease of -1.46% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/3/n/press8-2465881.jpg)
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/x/h/press11-2461177.jpg)
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/5/o/conf10-2445275.jpg)
Twist Bioscience to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/m/v/press11-2426804.jpg)
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/r/w/press1-2417864.jpg)
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers ...
![](https://cdn.snapi.dev/images/v1/z/i/press3-2407608.jpg)
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/v/r/conf3-2377952.jpg)
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/9/l/press10-2345989.jpg)
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/u/m/press9-2308285.jpg)
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/x/p/press4-2264315.jpg)
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers ...
![](https://cdn.snapi.dev/images/v1/l/i/press14-2261872.jpg)
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using ...
![](https://cdn.snapi.dev/images/v1/p/6/press19-2261875.jpg)
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/2/t/press1-2259712.jpg)
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/c/r/press18-2257416.jpg)
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/r/d/press15-2242121.jpg)
Twist Bioscience Expands Express Genes Rapid Synthesis Service
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/v/l/conf12-2230290.jpg)
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/h/x/press2-2220061.jpg)
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers ...
![](https://cdn.snapi.dev/images/v1/c/2/press6-2218004.jpg)
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/3/c/conf18-2199890.jpg)
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/0/n/press14-2163043.jpg)
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/s/p/press19-2156772.jpg)
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/r/o/conf10-2154430.jpg)
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/o/a/conf17-2137595.jpg)
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/r/k/press17-2130147.jpg)
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
![](https://cdn.snapi.dev/images/v1/p/r/press12-2091341.jpg)
Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
BERLIN--(BUSINESS WIRE)--Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silic...